Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / CD Molecules

Recombinant Mouse CD258/TNFSF14/LIGHT Protein, N-His

Catalog #:   YMA70801 Specific References (51) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q9QYH9
Protein length: Asp72-Val239
Overview

Catalog No.

YMA70801

Expression system

E. coli

Species

Mus musculus (Mouse)

Protein length

Asp72-Val239

Predicted molecular weight

20.66 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q9QYH9

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Herpes virus entry mediator ligand, LIGHT, CD258, HVEM-L, HVEML, TNFSF14, Tumor necrosis factor ligand superfamily member 14, Herpesvirus entry mediator ligand

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Mouse CD258/TNFSF14/LIGHT protein
References

Zhang, J., Xiong, X., Li, J., Luo, C., Su, Q., Hao, X., Wu, Q., and Huang, W. (2024). Valtrate suppresses TNFSF14-mediated arrhythmia after myocardial ischemia-reperfusion via inducing N-linked glycosylation of LTβR to regulate MGA/MAX/c-Myc/Cx43. J Cardiovasc Pharmacol.

Targeting B and T lymphocyte attenuator in cancer immunotherapy., PMID:40480574

Combination therapy blocking TNF superfamily members 14 and 15 reverses pulmonary fibrosis., PMID:40127640

Clinical Significance of TNFSF14/LIGHT and CD160 in Gastric Cancer and Peptic Ulcer Dyspepsia., PMID:39205564

Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction., PMID:38958133

Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker., PMID:38373842

TNFSF14 mediates the impact of docosahexaenoic acid on atopic dermatitis: a Mendelian randomization study., PMID:38235898

Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis., PMID:37722959

LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells., PMID:37552689

High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome., PMID:36917420

Elevated Levels of the Cytokine LIGHT in Pediatric Crohn's Disease., PMID:36688686

Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas., PMID:36341396

A LIGHT-HVEM/LTβR axis contributes to the fibrosis of intrauterine adhesion., PMID:35987137

LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade., PMID:35817517

Hepatic stellate cell mediates transcription of TNFSF14 in hepatocellular carcinoma cells via H2S/CSE-JNK/JunB signaling pathway., PMID:35292636

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome., PMID:34871182

The Contribution of LIGHT (TNFSF14) to the Development of Systemic Sclerosis by Modulating IL-6 and T Helper Type 1 Chemokine Expression in Dermal Fibroblasts., PMID:34838790

HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160., PMID:34709351

Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation., PMID:34359880

Genomic and functional evaluation of TNFSF14 in multiple sclerosis susceptibility., PMID:34353742

Abundant TNF-LIGHT expression in the airways of patients with asthma with persistent airflow limitation: Association with nitrative and inflammatory profiles., PMID:34244107

The tumor necrosis factor family molecules LIGHT and lymphotoxins in sinus mucosa of patients with chronic rhinosinusitis with or without nasal polyps., PMID:34083106

LIGHT (TNFSF14) enhances osteogenesis of human bone marrow-derived mesenchymal stem cells., PMID:33606781

LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells., PMID:33594067

Plasma TNFSF13B and TNFSF14 Function as Inflammatory Indicators of Severe Adenovirus Pneumonia in Pediatric Patients., PMID:33542721

Increased level of LIGHT/TNFSF14 is associated with survival in aneurysmal subarachnoid hemorrhage., PMID:33492677

LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis., PMID:33045563

Efficient Expansion of Human Granzyme B-Expressing B Cells with Potent Regulatory Properties., PMID:32948686

LIGHT aggravates sepsis-associated acute kidney injury via TLR4-MyD88-NF-κB pathway., PMID:32881263

Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS., PMID:32817460

Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160., PMID:32795404

The impact of TNFSF14 on prognosis and immune microenvironment in clear cell renal cell carcinoma., PMID:32725578

Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype., PMID:32712105

Shedding "LIGHT" on the Link between Bone and Fat in Obese Children and Adolescents., PMID:32635185

TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy., PMID:32499782

Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling., PMID:32310827

TNFSF14, a novel target of miR-326, facilitates airway remodeling in airway smooth muscle cells via inducing extracellular matrix protein deposition and proliferation., PMID:32118359

Differential Expression of Circulating Inflammatory Proteins Following Sport-Related Traumatic Brain Injury., PMID:32059364

Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age., PMID:31998285

LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss., PMID:31990039

LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients., PMID:31826304

Unique Sjögren's syndrome patient subsets defined by molecular features., PMID:31497844

Increased LIGHT leading to sFlt-1 elevation underlies the pathogenic link between hydatidiform mole and preeclampsia., PMID:31300808

The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection In Vivo Differently than the Absence of Other HVEM Cellular Ligands., PMID:31142672

Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients With Stable Coronary Artery Disease., PMID:30943772

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens., PMID:30405638

Green light and light stress in moth: influence on antioxidant enzymes in the oriental armyworm, Mythimna separata (Lepidoptera: Noctuidae)., PMID:30328544

Shedding Light on the Shade: How Nurseries Protect Their Children from Ultraviolet Radiation., PMID:30134509

Circulating soluble LIGHT/TNFSF14 is increased and associated with IL-8 concentration in chronic spontaneous urticaria., PMID:29952668

Investigation of Plasma Inflammatory Profile in Diabetic Patients With Abdominal Aortic Aneurysm: A Pilot Study., PMID:29940819

TNFSF14 inhibits melanogenesis via NF-kB signaling in melanocytes., PMID:29730385

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Mouse CD258/TNFSF14/LIGHT Protein, N-His [YMA70801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only